SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.
Status:
Completed
Trial end date:
2019-04-26
Target enrollment:
Participant gender:
Summary
A Phase 3, randomized, double-masked, vehicle-controlled trial to evaluate the safety and
efficacy of ADX-102 ophthalmic solution in Subjects with non-infectious anterior-uveitis.